A detailed history of Israel Englander (Millennium Management LLC) transactions in Humacyte, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 264,666 shares of HUMA stock, worth $2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
264,666
Previous 1,295,366 79.57%
Holding current value
$2 Million
Previous $3.68 Million 77.62%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$2.57 - $4.84 $2.65 Million - $4.99 Million
-1,030,700 Reduced 79.57%
264,666 $823,000
Q4 2023

Feb 14, 2024

BUY
$1.99 - $3.12 $2.58 Million - $4.04 Million
1,295,366 New
1,295,366 $3.68 Million
Q1 2023

May 15, 2023

BUY
$2.11 - $3.25 $58,816 - $90,593
27,875 New
27,875 $86,000
Q3 2022

Nov 14, 2022

BUY
$1.22 - $5.14 $30,640 - $129,091
25,115 Added 6.3%
423,880 $1.38 Million

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $778M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.